Showing items 1–100
CD123 binding proteins and related compositions and methods
Grant US-11939392-B2
United States of America
Antibodies against signal-regulatory protein alpha and methods of use
Grant US-11939393-B2
United States of America
Specific binding molecules
Grant US-11919949-B2
United States of America
Methods of treating gastrointestinal diseases characterized by inflammatory cells
Grant US-11919968-B2
United States of America
Methods of inhibiting complement factor H (CFH) comprising administering an antibody that…
Grant US-11897946-B2
United States of America
Anti-dengue virus antibodies having cross-reactivity to Zika virus and methods of use
Grant US-11891432-B2
United States of America
Glycated CD59 peptides, their preparation, and uses thereof
Grant US-11891448-B2
United States of America
Method of treating ocular conditions by administering an antibody that activates Tie2 and…
Grant US-11873334-B2
United States of America
Antibodies to citrullinated proteins
Grant US-11866512-B2
United States of America
Interferon beta antibodies and uses thereof
Grant US-11858986-B2
United States of America
Antibodies to zika virus and methods of use thereof
Grant US-11834494-B2
United States of America
Antibodies that bind human protein tyrosine phosphatase beta (HPTPbeta) and uses thereof
Grant US-11814425-B2
United States of America
Polypeptide binding complement component C5 or serum albumin and fusion protein thereof
Grant CN-111201246-B
China
Anti-SIRP-alpha antibodies and methods of use thereof
Grant US-11779642-B2
United States of America
Binding proteins to the human thrombin receptor, PAR4
Grant US-11780915-B2
United States of America
Human antibodies to influenza hemagglutinin
Grant US-11780907-B2
United States of America
Specific conjugation linkers, specific immunoconjugates thereof, methods of making and…
Grant US-11779663-B2
United States of America
Neutralizing antibodies to HIV-1 Env and their use
Grant US-11760790-B2
United States of America
Anti-coagulation factor XI antibodies
Grant US-11661460-B2
United States of America
Humanized anti-PD-L1 antibodies
Grant US-11643466-B2
United States of America
Treatment of headache using anti-CGRP antibodies
Grant US-11639381-B2
United States of America
Acute treatment and rapid treatment of headache using anti-CGRP antibodies
Grant US-11639380-B2
United States of America
Fusion proteins and antibodies targeting human red blood cell antigens
Grant US-11629198-B2
United States of America
Anti-spike glycoprotein antibodies and the therapeutic use thereof
Grant US-11623949-B2
United States of America
Siglec-9-neutralizing antibodies
Grant US-11623954-B2
United States of America
Identifying human B cells expressing anti-allergen antibodies
Grant US-11613569-B2
United States of America
Anti-CD3 antibodies and uses thereof
Grant US-11603405-B2
United States of America
Anti-human PD-L2 antibodies
Grant US-11591399-B2
United States of America
ANTIBODIES TO FELINE MCDONOUGH SARCOMA (FMS)-LIKE TYROSINE KINASE 3 RECEPTOR LIGAND (FLT3L…
Application US-20230056815-A1
United States of America
Antibodies targeting Glycoprotein VI
Grant US-11542329-B2
United States of America
Anti-coagulation factor XI antibodies
Grant US-11512142-B2
United States of America
CD123 BINDING PROTEINS AND RELATED COMPOSITIONS AND METHODS
Application US-20220363773-A1
United States of America
ANTIGEN-BINDING AND ANTIGEN DEGRADATION CONSTRUCTS
Application WO-2022240757-A1
World Intellectual Property Organisation (WIPO)
Polypeptides that bind complement component C5 or serum albumin and fusion proteins…
Grant US-11498960-B2
United States of America
Intracellular nanobody targeting T4SS effector inhibits ehrlichia infection
Grant US-11492391-B1
United States of America
Anti-coagulation factor XI antibodies
Grant US-11485794-B2
United States of America
Anti-respiratory syncytial virus antibodies, and methods of their generation and use
Grant US-11485775-B2
United States of America
Anti-coagulation factor XI antibodies
Grant US-11479615-B2
United States of America
ANTIBODIES AGAINST SIGNAL-REGULATORY PROTEIN ALPHA AND METHODS OF USE
Application US-20220324996-A1
United States of America
Anti-PD-1 antibodies and methods of making and using thereof
Grant US-11466084-B2
United States of America
Anti-IL-2 antibodies and compositions and uses thereof
Grant US-11459385-B2
United States of America
Anti-tissue factor antibodies, antibody-drug conjugates, and related methods
Grant US-11447566-B2
United States of America
Antibodies against N-acetylglucosamine and N-acetyl-galactosamine
Grant US-11446328-B2
United States of America
Anti-SIRPa Antibodies and Methods of Use Thereof
Application US-20220289844-A1
United States of America
Allergen-specific antibodies
Grant US-11434282-B2
United States of America
Dual antigen-induced bipartite functional complementation
Grant US-11427644-B2
United States of America
MONOCLONAL ANTIBODY, MEASUREMENT REAGENT FOR CYTOKERATIN 18 FRAGMENT, REAGENT KIT, AND…
Application US-20220267427-A1
United States of America
Saccharide-based biomarkers and therapeutics
Grant US-11421039-B2
United States of America
ANTI-SPIKE GLYCOPROTEIN ANTIBODIES AND THE THERAPEUTIC USE THEREOF
Application US-20220251174-A1
United States of America
Antibodies against signal-regulatory protein alpha and methods of use
Grant US-11401338-B2
United States of America
Anti-CD47 antibodies and uses thereof
Grant US-11401329-B2
United States of America
Humanized anti-S100A9 antibody and uses thereof
Grant US-11359010-B2
United States of America
Antibodies to LILRB2
Grant US-11359019-B2
United States of America
GLYCATED CD59 PEPTIDES, THEIR PREPARATION, AND USES THEREOF
Application US-20220162333-A1
United States of America
Humanised ADAMTS13 binding antibodies
Grant US-11339226-B2
United States of America
Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or…
Grant US-11325967-B2
United States of America
Anti-SIRPA antibodies and methods of use thereof
Grant US-11319373-B2
United States of America
Humanized Anti-PD-L1 Antibodies
Application US-20220112290-A1
United States of America
Anti-IGF antibodies
Grant US-11299538-B2
United States of America
Anti-PD-L1 antibodies and methods of using the same for detection of PD-L1
Grant US-11292843-B2
United States of America
Antibodies against signal-regulatory protein α and methods of use
Grant US-11292850-B2
United States of America
ANTIBODIES RECOGNIZING TAU
Application US-20220089702-A1
United States of America
ANTI-FACTOR IX PADUA ANTIBODIES
Application US-20220056150-A1
United States of America
CD123 binding proteins and related compositions and methods
Grant US-11242400-B2
United States of America
ANTI-CHI3L1 ANTIBODIES FOR THE DETECTION AND/OR TREATMENT OF NONALCOHOLIC FATTY LIVER…
Application US-20220002440-A1
United States of America
Anti-LAG-3 antibody
Grant US-11198730-B2
United States of America
IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS
Grant EP-3165539-B1
European Patent Office
HUMAN ANTIBODIES TO INFLUENZA HEMAGGLUTININ
Application US-20210371505-A1
United States of America
VARIANT NUCLEIC ACID LIBRARIES FOR CORONAVIRUS
Application US-20210355194-A1
United States of America
DUAL ANTIGEN-INDUCED BIPARTITE FUNCTIONAL COMPLEMENTATION
Application EP-3907241-A1
European Patent Office
Factor XI antibodies and methods of use
Grant US-11168147-B2
United States of America
Glycated CD59 peptides, their preparation, and uses thereof
Grant US-11161910-B2
United States of America
ANTIBODIES TO ZIKA VIRUS AND METHODS OF USE THEREOF
Application US-20210332111-A1
United States of America
Anti-coagulation factor VIII antibody and use thereof
Grant US-11155635-B2
United States of America
Anti-CHI3L1 antibodies for the detection and/or treatment of nonalcoholic fattly liver…
Grant US-11155638-B2
United States of America
Thrombin-binding antibody molecules and uses thereof
Grant US-11155637-B2
United States of America
Specific conjugation linkers, specific immunoconjugates thereof, methods of making and…
Grant US-11129910-B2
United States of America
Humanized anti-PD-L1 antibodies
Grant US-11124572-B2
United States of America
Anti-CGRP compositions and use thereof
Grant US-11111289-B2
United States of America
Red blood cell targeted factor VIII and method of using the same
Grant US-11104718-B2
United States of America
Anti-factor IX Padua antibodies
Grant US-11098132-B2
United States of America
Anti-CD79 antibodies and their uses
Grant US-11078276-B2
United States of America
ANTIBODIES TARGETING GLYCOPROTEIN VI
Application US-20210214435-A1
United States of America
BINDING PROTEINS TO THE HUMAN THROMBIN RECEPTOR, PAR4
Application US-20210179707-A1
United States of America
FUSION PROTEINS AND ANTIBODIES TARGETING HUMAN RED BLOOD CELL ANTIGENS
Application US-20210171652-A1
United States of America
Anti-peripheral lymph node addressin antibodies and uses thereof
Grant US-11028176-B2
United States of America
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with…
Grant US-11027018-B2
United States of America
INTERFERON BETA ANTIBODIES AND USES THEREOF
Application US-20210163588-A1
United States of America
ANTI-KLK7 ANTIBODIES, ANTI-KLK5 ANTIBODIES, MULTISPECIFIC ANTI-KLK5/KLK7 ANTIBODIES, AND…
Application US-20210130492-A1
United States of America
IMMUNOGLOBULINS AND USES THEREOF
Application US-20210094998-A1
United States of America
COMPLEMENT FACTOR H ANTIBODIES
Application US-20210061891-A1
United States of America
ANTI-DENGUE VIRUS ANTIBODIES HAVING CROSS-REACTIVITY TO ZIKA VIRUS AND METHODS OF USE
Application US-20210017256-A1
United States of America
SPECIFIC BINDING MOLECULES
Application US-20200407437-A1
United States of America
POLYPEPTIDES THAT BIND COMPLEMENT COMPONENT C5 OR SERUM ALBUMIN AND FUSION PROTEINS…
Application US-20200399351-A1
United States of America
ANTI-HUMAN PD-L2 ANTIBODIES
Application US-20200369772-A1
United States of America
SIGLEC-9-NEUTRALIZING ANTIBODIES
Application US-20200369765-A1
United States of America
ANTIBODIES TO CITRULLINATED PROTEINS
Application US-20200291133-A1
United States of America
Use of anti-CGRP antibodies and antibody fragments to treat diarrhea in subjects with…
Grant US-10765746-B2
United States of America
Means and methods for treating HBV infection and associated conditions
Grant US-10730943-B2
United States of America
Showing items 1–100